Clinical Trials Browser

Completed × INDUSTRY × mavorixafor × Clear all

NCT02667886 2024-10-03

Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma

Phase 1/2 Completed

74 enrolled 20 charts

Carcinoma, Renal Cell

NCT04274738 2024-08-27

A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4

Phase 1 Completed

Waldenstrom Macroglobulinemia

NCT02823405 2020-07-07

X4P-001-MELA

Phase 1 Completed

Melanoma